377 related articles for article (PubMed ID: 27089238)
21. Structure and activation mechanism of the human liver-type glutaminase GLS2.
Ferreira IM; Quesñay JEN; Bastos AC; Rodrigues CT; Vollmar M; Krojer T; Strain-Damerell C; Burgess-Brown NA; von Delft F; Yue WW; Dias SM; Ambrosio AL
Biochimie; 2021 Jun; 185():96-104. PubMed ID: 33746066
[TBL] [Abstract][Full Text] [Related]
22. Selective activation of the proto-oncogene c-jun promoter by the transforming protein v-Rel.
Fujii M; Minamino T; Nomura M; Miyamoto KI; Tanaka J; Seiki M
Oncogene; 1996 May; 12(10):2193-202. PubMed ID: 8668346
[TBL] [Abstract][Full Text] [Related]
23. Transcription factor ATF3 partially transforms chick embryo fibroblasts by promoting growth factor-independent proliferation.
Perez S; Vial E; van Dam H; Castellazzi M
Oncogene; 2001 Mar; 20(9):1135-41. PubMed ID: 11314051
[TBL] [Abstract][Full Text] [Related]
24. Somatic excision demonstrates that c-Jun induces cellular migration and invasion through induction of stem cell factor.
Katiyar S; Jiao X; Wagner E; Lisanti MP; Pestell RG
Mol Cell Biol; 2007 Feb; 27(4):1356-69. PubMed ID: 17145782
[TBL] [Abstract][Full Text] [Related]
25. Regulation of the rat CYP4A2 gene promoter by c-Jun and octamer binding protein-1.
Fiala-Beer E; Lee AC; Murray M
Int J Biochem Cell Biol; 2007; 39(6):1235-47. PubMed ID: 17481938
[TBL] [Abstract][Full Text] [Related]
26. Glutaminase: a hot spot for regulation of cancer cell metabolism?
Erickson JW; Cerione RA
Oncotarget; 2010 Dec; 1(8):734-40. PubMed ID: 21234284
[TBL] [Abstract][Full Text] [Related]
27. A Time for MYC: Metabolism and Therapy.
Dang CV
Cold Spring Harb Symp Quant Biol; 2016; 81():79-83. PubMed ID: 28174256
[TBL] [Abstract][Full Text] [Related]
28. Halofuginone inhibition of COL1A2 promoter activity via a c-Jun-dependent mechanism.
McGaha TL; Kodera T; Spiera H; Stan AC; Pines M; Bona CA
Arthritis Rheum; 2002 Oct; 46(10):2748-61. PubMed ID: 12384935
[TBL] [Abstract][Full Text] [Related]
29. The Wilms' tumor gene product represses the transcription of thrombospondin 1 in response to overexpression of c-Jun.
Dejong V; Degeorges A; Filleur S; Ait-Si-Ali S; Mettouchi A; Bornstein P; Binétruy B; Cabon F
Oncogene; 1999 May; 18(20):3143-51. PubMed ID: 10340386
[TBL] [Abstract][Full Text] [Related]
30. An unconventional KITENIN/ErbB4-mediated downstream signal of EGF upregulates c-Jun and the invasiveness of colorectal cancer cells.
Bae JA; Yoon S; Park SY; Lee JH; Hwang JE; Kim H; Seo YW; Cha YJ; Hong SP; Kim H; Chung IJ; Kim KK
Clin Cancer Res; 2014 Aug; 20(15):4115-28. PubMed ID: 24893630
[TBL] [Abstract][Full Text] [Related]
31. Filamin a mediates HGF/c-MET signaling in tumor cell migration.
Zhou AX; Toylu A; Nallapalli RK; Nilsson G; Atabey N; Heldin CH; Borén J; Bergo MO; Akyürek LM
Int J Cancer; 2011 Feb; 128(4):839-46. PubMed ID: 20473907
[TBL] [Abstract][Full Text] [Related]
32. NANOG upregulates c-Jun oncogene expression through binding the c-Jun promoter.
Lin Y; Xiong F; Zhou Y; Wu X; Liu F; Xue S; Chen H
Mol Carcinog; 2015 Nov; 54(11):1407-16. PubMed ID: 25213759
[TBL] [Abstract][Full Text] [Related]
33. Metabolic fingerprinting reveals extensive consequences of GLS hyperactivity.
Rumping L; Pras-Raves ML; Gerrits J; Tang YF; Willemsen MA; Houwen RHJ; van Haaften G; van Hasselt PM; Verhoeven-Duif NM; Jans JJM
Biochim Biophys Acta Gen Subj; 2020 Mar; 1864(3):129484. PubMed ID: 31734463
[TBL] [Abstract][Full Text] [Related]
34. Up-regulation of cyclin D1 by JNK1/c-Jun is involved in tumorigenesis of human embryo lung fibroblast cells induced by a low concentration of arsenite.
Li Y; Shen L; Xu H; Pang Y; Xu Y; Ling M; Zhou J; Wang X; Liu Q
Toxicol Lett; 2011 Oct; 206(2):113-20. PubMed ID: 21726611
[TBL] [Abstract][Full Text] [Related]
35. c-Jun enhancement of androgen receptor transactivation is associated with prostate cancer cell proliferation.
Chen SY; Cai C; Fisher CJ; Zheng Z; Omwancha J; Hsieh CL; Shemshedini L
Oncogene; 2006 Nov; 25(54):7212-23. PubMed ID: 16732317
[TBL] [Abstract][Full Text] [Related]
36. Tristetraprolin induces cell cycle arrest in breast tumor cells through targeting AP-1/c-Jun and NF-κB pathway.
Xu L; Ning H; Gu L; Wang Q; Lu W; Peng H; Cui W; Ying B; Ross CR; Wilson GM; Wei L; Wold WS; Liu J
Oncotarget; 2015 Dec; 6(39):41679-91. PubMed ID: 26497679
[TBL] [Abstract][Full Text] [Related]
37. v-Jun represses c-jun proto-oncogene expression in vivo through a 12-O-tetradecanoylphorbol-13-acetate-responsive element in the proximal gene promoter.
Hussain S; Kilbey A; Gillespie DA
Cell Growth Differ; 1998 Aug; 9(8):677-86. PubMed ID: 9716184
[TBL] [Abstract][Full Text] [Related]
38. Targeting Glutamine Induces Apoptosis: A Cancer Therapy Approach.
Chen L; Cui H
Int J Mol Sci; 2015 Sep; 16(9):22830-55. PubMed ID: 26402672
[TBL] [Abstract][Full Text] [Related]
39. Antiapoptotic properties of MALT1 protease are associated with redox homeostasis in ABC-DLBCL cells.
Zhu L; Tang F; Lei Z; Guo C; Song Y; Huang J; Xia X
Mol Carcinog; 2019 Dec; 58(12):2340-2352. PubMed ID: 31556968
[TBL] [Abstract][Full Text] [Related]
40. [
Zhou R; Pantel AR; Li S; Lieberman BP; Ploessl K; Choi H; Blankemeyer E; Lee H; Kung HF; Mach RH; Mankoff DA
Cancer Res; 2017 Mar; 77(6):1476-1484. PubMed ID: 28202527
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
